Verrica Pharmaceuticals Inc.: Verrica Pharmaceuticals Reports Third Quarter 2025 Financial Results

Company reports $14.3 million in revenue in Q3'25, consisting of $3.6 million in YCANTH® revenue and $10.7 million of license and collaboration revenue - - Reports positive feedback from the FDA ...
Ventureburn

Tether Eyes Major $1.2Billion Move into Robotics with Neura Investment

Tether is in talks to lead a $1.2B funding round for Neura Robotics, valuing the company up to €10B as it expands.